Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44021745HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44014146HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44000462HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021746HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44033264HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44037432HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB00185
Drug NameCevimeline
Target IDBE0000045
UniProt IDP20309
Regulation Typeagonist
PubMed IDs17139284; 17016423; 18450949; 11752352
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Li X, Azlina A, Karabasil MR, Purwanti N, Hasegawa T, Yao C, Akamatsu T, Hosoi K: Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline, an M3 muscarinic receptor agonist. Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G112-G123. doi: 10.1152/ajpgi.00359.2007. Epub 2008 May 1.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationAzaspirodecane derivatives
SMILESCC1O[C@@]2(CS1)CN1CCC2CC1
Pathways
PharmGKBPA164754754
ChEMBL